0000

Shenzhen Neptunus Bioengineering Co., Ltd. (000078)

Market Closed
16 May, 06:57
XSHE XSHE
¥
2. 35
+0.02
+0.86%
¥
6.45B Market Cap
- P/E Ratio
0.08% Div Yield
19,195,291 Volume
- Eps
¥ 2.33
Previous Close
Day Range
2.32 2.36
Year Range
2.07 3.19
Earnings results expected in 25 days

Summary

000078 closed Friday higher at ¥2.35, an increase of 0.86% from Thursday's close, completing a monthly decrease of -0.84% or ¥0.02. Over the past 12 months, 000078 stock lost -7.48%.
000078 is not paying dividends to its shareholders.
The last earnings report, released on Oct 31, 2024, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.22%, based on the last three reports. The next scheduled earnings report is due on Jun 13, 2025.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on XSHE (CNY).
Want to track 000078 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

000078 Chart

Shenzhen Neptunus Bioengineering Co., Ltd. (000078) FAQ

What is the stock price today?

The current price is ¥2.35.

On which exchange is it traded?

Shenzhen Neptunus Bioengineering Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 000078.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 6.45B.

What is the earnings per share?

The EPS is 0.

When is the next earnings date?

The next earnings report will release on Jun 13, 2025.

Has Shenzhen Neptunus Bioengineering Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Shenzhen Neptunus Bioengineering Co., Ltd. Profile

Drug Manufacturers - Specialty & Generic Industry
Healthcare Sector
Mr. Feng Zhang CEO
XSHE Exchange
CNE000000X95 ISIN
CN Country
9,093 Employees
- Last Dividend
27 May 2016 Last Split
7 Aug 1998 IPO Date

Overview

Shenzhen Neptunus Bioengineering Co., Ltd., founded in 1989 and headquartered in Shenzhen, China, is a prominent company specializing in the research and development, production, and sales of a diverse range of medical products. These include Chinese patent medicines, infusion products, and western medicine preparations. The company has carved a niche for itself in the healthcare industry by providing high-quality medications and medical supplies across various therapeutic areas. It is deeply involved in generic drug quality consistency evaluation and offers valuable technical support alongside its comprehensive R&D activities. Additionally, Shenzhen Neptunus extends its services to the distribution of drugs and medical devices, catering to hospitals, medical institutions, and a network of drug retail institutions and distributors, enhancing its role in the medical supply chain by providing essential value-added services.

Products and Services

  • Oryzanol Tablets

    These tablets are commonly used for managing elevated cholesterol levels and symptoms of menopause, showcasing Neptunus Bioengineering's dedication to cardiovascular health and wellbeing.

  • Chlorpheniramine Tablets and Maleate Tablets

    A medication designed for the relief of allergic symptoms, such as runny nose, itching of the skin, and watery eyes, illustrating the company’s focus on providing solutions for allergic reactions and related conditions.

  • Rifampicin Capsules

    Targeted toward combating infectious diseases, these capsules are important for treating tuberculosis, leveraging Neptunus Bioengineering's strength in addressing infectious and serious health conditions.

  • Technical Support for Generic Drug Quality Consistency Evaluation

    The company provides significant technical support services aimed at enhancing the quality and efficacy of generic medications, ensuring they meet the rigorous standards for therapeutic equivalence to their branded counterparts.

  • Distribution of Drugs, Medical Devices, and Other Medical Supplies

    Shenzhen Neptunus not only manufactures but also distributes a wide range of drugs, medical devices, and supplies, facilitating the comprehensive availability of essential health products to hospitals, institutions, and retailers.

  • Value-Added Services for Hospitals, Medical Institutions, and Drug Retail Institutions and Distributors

    Through its distribution network, the company offers various value-added services designed to enhance the operational efficiency of healthcare providers and drug retailers, showcasing its commitment to supporting the broader healthcare ecosystem.

In addition to the above products and services, Shenzhen Neptunus Bioengineering Co., Ltd. has a diversified portfolio that addresses multiple disease areas, including malignant tumors, cardiovascular and cerebrovascular diseases, neurodegenerative diseases, diabetes, and respiratory and digestive system diseases. This extensive range underscores the company's role as a key player in the pharmaceutical and bioengineering sector, with a broad impact on public health and medical research.

Contact Information

Address: Neptunus Galaxy Technology Building, Shenzhen, China, 518057
Phone: 86 755 2698 0336